Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) KSC

6,550.00

+20(+0.31%)

Updated at June 02 03:30PM

Currency In KRW

Valuation

Market Cap307.19B
Enterprise Value479.16B
P/E Ratio15.04
PEG Ratio-0.72
Price/Sales Ratio0.16
Price/Book Ratio0.5
Enterprise/Revenue0.28
Enterprise/EBITDA8.66

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue1.66T
Revenue/Share34,086.35
Gross Profit293.22B
EBITDA48.54B
Net Income20.97B
Diluted EPS521

Balance Sheet

Total Cash182.71B
Total Cash/Share3,679.1
Total Debt301.19B
Total Debt/Equity0.47
Current Ratio1.3
Book Value Per Share14,404.1

Price History

52-Week Change19.09
52-Week High12,800
52-Week Low5,500
Moving Average 50 Days8,117.4
Moving Average 200 Days6,788.4

Statistics

Average Volume380,622
Shares Outstanding40.24M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate100
Trailing Annual Dividend Yield1.53
Payout Ratio0.18
Last Split FactorN/A
Last Split DateN/A